PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12972984::ACT039566

MAVP

Evidence text

Paper-level observation

In vitro study further confirmed that MAVP significantly reduced the expression of the mechanosensitive pain-related receptor TRPA1 in the DRG neuronal cell line (Fig. S16).
textConfidence: medium

Assay observation

Activity
Other
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
significantly reduced TRPA1 expression
Normalized measurement
=6
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
DRG neuronal cell line FH-R182
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.